Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D Receptor Partners and Regulatory Networks: Study Summary

Previous related pageVitamin D Receptor Partners and Regulatory Networks: Full Evidence ReviewNext related pageVitamin D Receptor Partners and Regulatory Networks: Full Evidence Review
Study at a glance

What question did the studies ask?

Researchers asked which proteins work with the vitamin D receptor and how strong the evidence is. The receptor is a protein that responds to active vitamin D. Studies used human and rat cell models, isolated protein parts and mice. Some cell models came from cancers. These were not clinical treatment trials.

What did the researchers find?

Some experiments found direct binding between isolated protein parts. Others found proteins together in cell extracts or at related DNA regions. DNA carries genetic information. Finding proteins at the same DNA region does not prove that they directly bind each other.

Changing a gene or protein supported particular changes in gene activity. Many proposed connections between gene-regulating proteins were not fully tested. A mouse blood-vessel study used toxic injected vitamin D3 doses and produced harmful mineral deposits. It does not predict ordinary supplement effects. In another mouse experiment, a receptor unable to bind hormone normally still preserved selected hair-cycle functions. Receptor loss is different from low vitamin D supply.

What does this mean?

Some experiments used calcitriol, the active vitamin D hormone. Others used a laboratory-made receptor activator with a separate substance limiting another protein’s action. These exposures differ from oral vitamin D3. The studies support specific partnerships with important limits. They do not establish that the same set of proteins always improves function or that every tissue effect comes from one contact between two proteins. They do not provide a personal treatment dose.

Read the full article below ↓

Several proteins can cooperate with the vitamin D receptor, but different tests provide different strengths of evidence. Finding proteins together, finding them near the same DNA region and showing direct binding are not the same result. This summary explains those distinctions and their limits. For the detailed evidence, read Vitamin D Receptor Partners and Regulatory Networks: Full Evidence Review.

What are the researchers trying to establish?

The vitamin D receptor is a protein responding to active vitamin D. Vitamin D Receptors explains the receptor, and Vitamin D and Nuclear Receptors places it within its wider family. Other proteins help control which genes are used. The broader question is introduced in Vitamin D and Transcription Factors. DNA carries genetic information; gene activity is explained in Vitamin D and Gene Expression.

A predicted DNA sequence is a possible binding site, not proof of binding. Finding proteins together in a cell extract can show association without proving direct contact. Tests with isolated protein parts can investigate direct binding, but do not by themselves establish how that contact works in a whole tissue. Changing a protein can test whether it contributes to a response.

What did the experiments show?

A human immune-cell model grown from a blood cancer produced a predicted network of gene-regulating proteins. Among two selected example factors, binding was examined for both, but only one was selectively reduced to test its contribution. Many predicted connections remained untested. Reducing the tested factor caused some responses to disappear, others to appear and others to remain. [1]

A kidney-scarring study included direct binding between isolated protein parts and interference with a regulator’s ability to bind DNA. Liver-cell experiments instead measured related DNA-binding patterns and responses to changing the regulatory proteins. Both provide useful evidence, but they do not establish one identical mechanism in every tissue. [2] [3]

Another study examined changes between groups of proteins that alter how DNA is packaged. It combined a laboratory-made receptor activator with a separate substance limiting another protein’s action. Insulin is a hormone that helps regulate blood sugar. Selected blood-sugar and insulin findings in mice did not establish an ordinary vitamin D3 treatment for people. They also did not prove that one protein contact caused all the effects. [4]

In rat cells that can mature into myelin-producing cells, receptor association and tests reducing receptor function supported a role in maturation. Myelin insulates nerve fibres. The extra response to calcitriol, the active vitamin D hormone, depended on laboratory conditions. The specific contact between the receptor pair was not isolated as the sole cause. [5]

A mouse blood-vessel study linked regulatory cooperation with harmful mineral deposits under toxic injected vitamin D3 exposure. Cooperation therefore does not automatically mean benefit. A separate mouse hair-cycle experiment found that a receptor unable to bind hormone normally still preserved selected functions. Receptor loss is not the same as low vitamin D supply, and this did not show that every skin function is independent of hormone binding. [6] [7]

A separate study used human colon cells grown as three-dimensional cultures to examine a DNA-sequence difference near POLB, a gene involved in DNA repair. Tests of gene control and receptor binding supported a regulatory role for that DNA region. A gene message could rise without a protein rise at the same time. The researchers did not edit the sequence in its original position to prove that it caused every response. They did not demonstrate better DNA repair or cancer prevention, or establish POLB as a physical partner of the receptor. [8]

What can be concluded?

Some partnerships have substantial support from protein and cell experiments. Many proposed network connections are less certain, and a binding test is not automatically proof of a tissue outcome. The findings depend on which cells and DNA regions were tested, which receptor form was present and which other signals were active. They do not establish that oral vitamin D3 reproduces every laboratory response or provide a personal treatment dose.

Scientific sources

[1] A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T, Schulz MH, Günther S, Gilsbach R, Neme A, Carlberg C, Brandes RP, Seuter S. Scientific reports. 2021;11(1):6518. DOI 10.1038/s41598-021-86032-5; PMID 33753848; PMCID PMC7985518.

[2] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.

[3] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.

[4] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.

[5] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.

[6] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.

[7] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.

[8] Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB. Witonsky D, Laxman B, Usman H, Bielski MC, Lawrence KM, Kupfer SS. PLoS genetics. 2026;22(1):e1011983. DOI 10.1371/journal.pgen.1011983; PMID 41505470; PMCID PMC12810902.

Related reading

Physiology

Vitamin D Receptors

A physiology-first explanation of vitamin D receptors, covering cellular detection, transcriptional regulation, signalling integration, and tissue-specific responsiveness.

Read more →

Original sources

Source

A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes

The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).

Publication details

[1] A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T, Schulz MH, Günther S, Gilsbach R, Neme A, Carlberg C, Brandes RP, Seuter S. Scientific reports. 2021;11(1):6518. DOI 10.1038/s41598-021-86032-5; PMID 33753848; PMCID PMC7985518.

Read more →
Source

A nonclassical vitamin D receptor pathway suppresses renal fibrosis.

[2] A nonclassical vitamin D receptor pathway suppresses renal fibrosis.

Publication details

[2] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.

Read more →
Source

A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.

[3] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.

Publication details

[3] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.

Read more →
Source

Vitamin D Switches BAF Complexes to Protect β Cells.

[4] Vitamin D Switches BAF Complexes to Protect β Cells.

Publication details

[4] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.

Read more →
Source

Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.

[5] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.

Publication details

[5] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.

Read more →
Source

Functional Cooperation between Vitamin D Receptor and Runx2 in Vitamin D-Induced Vascular Calcification

The transdifferentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells has been implicated in the context of vascular calcification.

Publication details

[6] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.

Read more →
Source

Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis.

Published in Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.) (2005).

Publication details

[7] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.

Read more →
Source

Genomic profiling of active vitamin D colonic responses in African- and European-Americans identifies an ancestry-related regulatory variant of POLB

In our study, we aimed to understand how active vitamin D affects colon cells from people with African and European backgrounds.

Publication details

[8] Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB. Witonsky D, Laxman B, Usman H, Bielski MC, Lawrence KM, Kupfer SS. PLoS genetics. 2026;22(1):e1011983. DOI 10.1371/journal.pgen.1011983; PMID 41505470; PMCID PMC12810902.

Read more →